Naman Goel, Jatin Talwar, Sarang Agarwal, Loveneesh G. Krishna, Ashish Rustagi
{"title":"病灶内富血小板血浆注射与体外冲击波治疗足底筋膜炎的比较研究","authors":"Naman Goel, Jatin Talwar, Sarang Agarwal, Loveneesh G. Krishna, Ashish Rustagi","doi":"10.1016/j.jajs.2021.04.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Plantar Fasciitis<span><span> is a widely prevalent condition and is extremely disabling if it remains unresolved. Despite many available treatment modalities, the management of recalcitrant cases is still a dilemma. We conducted this study to evaluate and compare the role of two novel modalities: Intralesional PRP (Platelet Rich Plasma) injection and </span>Extra Corporeal Shockwave Therapy (ESWT) for the management of this condition.</span></p></div><div><h3>Methods</h3><p>60 patients with a clinical diagnosis of recalcitrant plantar fasciitis were randomized into 2 groups; PRP Group (n = 30) and ESWT Group (n = 30). In PRP group patients received 3 intralesional injections<span> of PRP and in ESWT group 3 sessions of Extra Corporeal Shockwave Therapy were administered. The Primary outcome measures were Visual Analogue Scale<span> (VAS) score, American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score, Roles and Maudsley Index and Heel Tenderness Index (HTI). The secondary outcome measures were complications. The patients were followed up for a period of 6 months and evaluated for various scores.</span></span></p></div><div><h3>Results</h3><p>At 6 months follow-up, significant results were found only on VAS score for both groups (p-value <0.05). However, both modalities resulted in significant clinical improvement with no complications reported. No statistically significant differences were reported between the two test groups.</p></div><div><h3>Conclusions</h3><p>Both autologous PRP and ESWT can become extremely useful modalities for management of recalcitrant cases of plantar fasciitis with no known adverse effects.</p></div>","PeriodicalId":38088,"journal":{"name":"Journal of Arthroscopy and Joint Surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jajs.2021.04.003","citationCount":"3","resultStr":"{\"title\":\"A comparative study between intralesional platelet rich plasma injection and extracorporeal shockwave therapy for the treatment of plantar fasciitis\",\"authors\":\"Naman Goel, Jatin Talwar, Sarang Agarwal, Loveneesh G. Krishna, Ashish Rustagi\",\"doi\":\"10.1016/j.jajs.2021.04.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Plantar Fasciitis<span><span> is a widely prevalent condition and is extremely disabling if it remains unresolved. Despite many available treatment modalities, the management of recalcitrant cases is still a dilemma. We conducted this study to evaluate and compare the role of two novel modalities: Intralesional PRP (Platelet Rich Plasma) injection and </span>Extra Corporeal Shockwave Therapy (ESWT) for the management of this condition.</span></p></div><div><h3>Methods</h3><p>60 patients with a clinical diagnosis of recalcitrant plantar fasciitis were randomized into 2 groups; PRP Group (n = 30) and ESWT Group (n = 30). In PRP group patients received 3 intralesional injections<span> of PRP and in ESWT group 3 sessions of Extra Corporeal Shockwave Therapy were administered. The Primary outcome measures were Visual Analogue Scale<span> (VAS) score, American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score, Roles and Maudsley Index and Heel Tenderness Index (HTI). The secondary outcome measures were complications. The patients were followed up for a period of 6 months and evaluated for various scores.</span></span></p></div><div><h3>Results</h3><p>At 6 months follow-up, significant results were found only on VAS score for both groups (p-value <0.05). However, both modalities resulted in significant clinical improvement with no complications reported. No statistically significant differences were reported between the two test groups.</p></div><div><h3>Conclusions</h3><p>Both autologous PRP and ESWT can become extremely useful modalities for management of recalcitrant cases of plantar fasciitis with no known adverse effects.</p></div>\",\"PeriodicalId\":38088,\"journal\":{\"name\":\"Journal of Arthroscopy and Joint Surgery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.jajs.2021.04.003\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Arthroscopy and Joint Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214963521000407\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroscopy and Joint Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214963521000407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3
摘要
目的足底筋膜炎是一种广泛流行的疾病,如果不加以解决,将导致严重的致残。尽管有许多可用的治疗方式,难治性病例的管理仍然是一个难题。我们进行了这项研究,以评估和比较两种新型治疗方式的作用:病灶内PRP(富血小板血浆)注射和体外冲击波治疗(ESWT)。方法60例临床诊断为顽固性足底筋膜炎的患者随机分为2组;PRP组(n = 30)和ESWT组(n = 30)。PRP组患者接受3次局内PRP注射,ESWT组患者接受3次体外冲击波治疗。主要观察指标为视觉模拟量表(VAS)评分、美国矫形足踝学会(AOFAS)踝关节-后足评分、Roles and Maudsley指数和跟部压痛指数(HTI)。次要结局指标为并发症。对患者进行为期6个月的随访,并进行各项评分。结果随访6个月,两组仅VAS评分有显著差异(p值<0.05)。然而,两种治疗方式均有显著的临床改善,无并发症报道。两组间无统计学差异。结论自体PRP和ESWT均可成为治疗顽固性足底筋膜炎的有效方法,且无已知的不良反应。
A comparative study between intralesional platelet rich plasma injection and extracorporeal shockwave therapy for the treatment of plantar fasciitis
Purpose
Plantar Fasciitis is a widely prevalent condition and is extremely disabling if it remains unresolved. Despite many available treatment modalities, the management of recalcitrant cases is still a dilemma. We conducted this study to evaluate and compare the role of two novel modalities: Intralesional PRP (Platelet Rich Plasma) injection and Extra Corporeal Shockwave Therapy (ESWT) for the management of this condition.
Methods
60 patients with a clinical diagnosis of recalcitrant plantar fasciitis were randomized into 2 groups; PRP Group (n = 30) and ESWT Group (n = 30). In PRP group patients received 3 intralesional injections of PRP and in ESWT group 3 sessions of Extra Corporeal Shockwave Therapy were administered. The Primary outcome measures were Visual Analogue Scale (VAS) score, American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score, Roles and Maudsley Index and Heel Tenderness Index (HTI). The secondary outcome measures were complications. The patients were followed up for a period of 6 months and evaluated for various scores.
Results
At 6 months follow-up, significant results were found only on VAS score for both groups (p-value <0.05). However, both modalities resulted in significant clinical improvement with no complications reported. No statistically significant differences were reported between the two test groups.
Conclusions
Both autologous PRP and ESWT can become extremely useful modalities for management of recalcitrant cases of plantar fasciitis with no known adverse effects.
期刊介绍:
Journal of Arthroscopy and Joint Surgery (JAJS) is committed to bring forth scientific manuscripts in the form of original research articles, current concept reviews, meta-analyses, case reports and letters to the editor. The focus of the Journal is to present wide-ranging, multi-disciplinary perspectives on the problems of the joints that are amenable with Arthroscopy and Arthroplasty. Though Arthroscopy and Arthroplasty entail surgical procedures, the Journal shall not restrict itself to these purely surgical procedures and will also encompass pharmacological, rehabilitative and physical measures that can prevent or postpone the execution of a surgical procedure. The Journal will also publish scientific research related to tissues other than joints that would ultimately have an effect on the joint function.